Bucol, Jimmy Y.

HRN: 13-50-98  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/01/2026
05/08/2026
IV
4.5g
Now Then Q8
COMPLICATED UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines